Merck’s Global Health Innovation Fund leaders Bill Taranto and Joel Krikston trace nontraditional careers into CVC, explain GHI’s shift to pharma-services and “enterprise coverage,” and spotlight global IDEA Studios plus wins like Livongo and Preventice. They share a bullish outlook on data-driven digital health, and advise entrepreneurs to focus on specific pharma use cases with validated results.